Hi Tech Pharmacal Co. (HITK) Tops Q3 Views

March 10, 2011 8:14 AM EST
Hi Tech Pharmacal Co. (NASDAQ: HITK) reported Q3 EPS of $0.79, $0.16 better than the analyst estimate of $0.63. Revenue for the quarter came in at $50 million versus the consensus estimate of $45.33 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings